chris_chi24 said:

Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Adding the part of the answer the thread has not reached. The mechanism that matters here is not stomach emptying, it is central. GLP-1 receptor agonism in the arcuate nucleus stimulates POMC neurons and suppresses AgRP/NPY signalling, which is why the effect is appetite and food salience rather than physical fullness. Delayed gastric emptying largely tachyphylaxes over the first months; the appetite effect does not.

That is the short version; the long version is somebody else's post.

Adding the numbers, since they settle part of this. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

One thing that is still open after chris_chi24’s answer:

Whether anyone has held at a sub-maximal dose long term and kept the result, or whether the maintenance data only exists at 2.4mg?

lisa_labSD said:

Keep the original post as written when you update it, and add the correction underneath.

I read this differently from lisa_labSD, on substance rather than tone. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

lisa_labSD said:

Keep the original post as written when you update it, and add the correction underneath.

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.